Safran SA: 2Q Preview – Expect strong 2Q but CFM SVs in 2027-28 watch item

Research evidence excerpt

Safran SA: 2Q Preview – Expect strong 2Q but CFM SVs in 2027-28 watch item

securities or instruments (e.g.,

options, futures, warrants, and contracts for differences). This document is not intended to provide personal investment advice and it does not take into account the specific investment

objectives, financial situation and the particular needs of, and is not directed to, any specific person(s). This document and its content do not constitute, and should not be considered to

constitute, investment advice for purposes of ERISA, the US tax code, the Investment Advisers Act or otherwise. Investors should seek financial advice regarding the appropriateness of

investing in financial instruments and implementing investment strategies discussed or recommended in this document and should understand that statements regarding future prospects

may not be realized. Any decision to purchase or subscribe for securities in any offering must be based solely on existing public information on such security or the information in the

prospectus or other offering document issued in connection with such offering, and not on this document.

Securities and other financial instruments referred to herein, or recommended, offered or sold by BofA Securities, are not insured by the Federal Deposit Insurance Corporation and are not

deposits or other obligations of any insured depository institution (including, Bank of America, N.A.). Investments in general and, derivatives, in particular, involve numerous risks, including,

among others, market risk, counterparty default risk and liquidity risk. No security, financial instrument or derivative is suitable for all investors. Digital assets are extremely speculative, volatile

and are largely unregulated.